argenx SE
Below you will find information from the register publication of inside information. The information has been provided by the organisation.
Registration date
20 jun 2025 - 19:00
Statutory name
argenx SE
Title
argenx Announces European Commission Approval of VYVGART Subcutaneous Injection for Chronic Inflammatory Demyelinating Polyneuropathy
Related downloads
Date last update: 14 July 2026